Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 158861-67-7, Ghrp-2, Kp-102, Pralmorelin (free base), Pralmorelin [inn], D-alanyl-3-(2-naphthalenyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide
Molecular Formula
C45H55N9O6
Molecular Weight
818.0  g/mol
InChI Key
HRNLPPBUBKMZMT-RDRUQFPZSA-N
FDA UNII
E6S6E1F19M

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-aminopropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide
2.1.2 InChI
InChI=1S/C45H55N9O6/c1-27(47)41(56)52-38(24-30-19-20-31-14-6-7-15-32(31)22-30)43(58)50-28(2)42(57)53-39(25-33-26-49-35-17-9-8-16-34(33)35)45(60)54-37(23-29-12-4-3-5-13-29)44(59)51-36(40(48)55)18-10-11-21-46/h3-9,12-17,19-20,22,26-28,36-39,49H,10-11,18,21,23-25,46-47H2,1-2H3,(H2,48,55)(H,50,58)(H,51,59)(H,52,56)(H,53,57)(H,54,60)/t27-,28+,36+,37-,38-,39+/m1/s1
2.1.3 InChI Key
HRNLPPBUBKMZMT-RDRUQFPZSA-N
2.1.4 Canonical SMILES
CC(C(=O)NC(CC1=CC2=CC=CC=C2C=C1)C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCCN)C(=O)N)N
2.1.5 Isomeric SMILES
C[C@H](C(=O)N[C@H](CC1=CC2=CC=CC=C2C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@H](CC5=CC=CC=C5)C(=O)N[C@@H](CCCCN)C(=O)N)N
2.2 Other Identifiers
2.2.1 UNII
E6S6E1F19M
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ala-beta-nal-ala-trp-phe-lys-nh2

2. Alanyl-(2-naphthyl)alanyl-alanyl-tryptophyl-phenylalanyl-lysinamide

3. D-alanyl-3-(2-naphthyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide

4. Ghrp-2

5. Growth Hormone-releasing Peptide-2

6. Kp 102

7. Kp-102

2.3.2 Depositor-Supplied Synonyms

1. 158861-67-7

2. Ghrp-2

3. Kp-102

4. Pralmorelin (free Base)

5. Pralmorelin [inn]

6. D-alanyl-3-(2-naphthalenyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide

7. L-lysinamide, D-alanyl-3-(2-naphthalenyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-

8. E6s6e1f19m

9. Growth Hormone-releasing Peptide 2

10. Kp 102

11. (2s)-6-amino-2-[[(2r)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-[[(2r)-2-aminopropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide

12. (s)-2-((2r,5s,8s,11r,14r)-5-((1h-indol-3-yl)methyl)-14-amino-2-benzyl-8-methyl-11-(naphthalen-2-ylmethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecanamido)-6-aminohexanamide

13. Way-gpa-748

14. D-alanyl-3-(2-naphthyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide

15. Kp-102d

16. Ghrp Kaken 100

17. Pralmorelin [mi]

18. Ghrp 2

19. Unii-e6s6e1f19m

20. Pralmorelin [who-dd]

21. Schembl424791

22. Chembl106593

23. Gtpl1092

24. Kp-102ln

25. Gpa-748

26. Kp-102t

27. Chebi:135890

28. Dtxsid601032404

29. Growth Hormone Releasing Peptide 2

30. Growth Hormone Releasing Peptide-2

31. Growth Hormone-releasing Peptide-2

32. Ex-a5533

33. Ala-beta-nal-ala-trp-phe-lys-nh2

34. Mfcd00674876

35. Zinc85537068

36. Akos037652421

37. D-ala-d-2-nal-ala-trp-d-phe-lys-nh2

38. Ds-3435

39. Ft-0656752

40. C73002

41. 861p677

42. Pralmorelin Trifluoroacetate Salt, >=97% (hplc)

43. Q21098924

44. D-ala-3-(2-naphthyl)-d-ala-ala-trp-d-phe-lys-nh2

45. Alanyl-(2-naphthyl)alanyl-alanyl-tryptophyl-phenylalanyl-lysinamide

2.4 Create Date
2006-07-28
3 Chemical and Physical Properties
Molecular Weight 818.0 g/mol
Molecular Formula C45H55N9O6
XLogP32.5
Hydrogen Bond Donor Count9
Hydrogen Bond Acceptor Count8
Rotatable Bond Count21
Exact Mass817.42753051 g/mol
Monoisotopic Mass817.42753051 g/mol
Topological Polar Surface Area256 Ų
Heavy Atom Count60
Formal Charge0
Complexity1440
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Growth Substances

Signal molecules that are involved in the control of cell growth and differentiation. (See all compounds classified as Growth Substances.)